Literature DB >> 12441947

The cost-effectiveness of treatment for varicocele related infertility.

David F Penson1, A David Paltiel, Harlan M Krumholz, Steven Palter.   

Abstract

PURPOSE: We compared the cost-effectiveness of 4 treatment strategies for varicocele related infertility from the perspective of the health care payor and patient.
MATERIALS AND METHODS: Cost-effectiveness analysis was performed by studying 4 treatment strategies, namely observation, surgical varicocelectomy followed by in vitro fertilization (IVF) if unsuccessful, gonadotropin stimulated intrauterine insemination (IUI) followed by IVF if unsuccessful, and immediate IVF. The main outcome measure was incremental cost per live delivery of any number of newborns.
RESULTS: Immediate IVF cost more per live delivery and was less effective than varicocelectomy/IVF or IUI/IVF. When electing the latter 2 procedures, the preferred approach depended on the choice of perspective. From the health care payor viewpoint each additional birth that resulted from choosing varicocelectomy/IVF over observation cost $52,152, while each additional birth that occurred by electing IUI/IVF over varicocelectomy/IVF cost $561,423. From the patient perspective, while varicocelectomy/IVF resulted in improved outcomes over observation, a rational decision maker would always be willing to pay the slightly higher cost of IUI/IVF (incremental cost per live birth versus observation $27,371) for the added benefit in effectiveness if they were initially willing to invest in varicocelectomy/IVF (incremental cost per live birth versus observation $27,618).
CONCLUSIONS: The optimal choice of treatment for varicocele related infertility depends strongly on the decision maker perspective. Regardless of perspective the most technologically advanced treatment, that is immediate IVF, is never favored. The findings of this study should be used to counsel infertile patients with varicocele that immediate IVF is not cost-effective.

Entities:  

Mesh:

Year:  2002        PMID: 12441947     DOI: 10.1097/01.ju.0000037487.02503.da

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

1.  Weighing cost versus efficacy in assisted reproductive technology.

Authors:  Michael P O'leary
Journal:  Rev Urol       Date:  2003

2.  Cost-effectiveness analysis reveals microsurgical varicocele repair is superior to percutaneous embolization in the treatment of male infertility.

Authors:  Jason Ronald Kovac; Jake Fantus; Larry I Lipshultz; Marc Anthony Fischer; Zachery Klinghoffer
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

3.  [Scrotal space-occupying lesions].

Authors:  B Szabados; B Ketting; C Stief; S Tritschler
Journal:  Urologe A       Date:  2014-09       Impact factor: 0.639

4.  In vitro fertilization and multiple pregnancies: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-10-01

5.  Effect of performing varicocelectomy before intracytoplasmic sperm injection on clinical outcomes in non-azoospermic males.

Authors:  Mehmet Ilker Gokce; Omer Gülpınar; Evren Süer; Murat Mermerkaya; Kaan Aydos; Onder Yaman
Journal:  Int Urol Nephrol       Date:  2013-02-08       Impact factor: 2.370

6.  Male infertility and varicocele: myths and reality.

Authors:  P D Kantartzi; Ch D Goulis; G D Goulis; I Papadimas
Journal:  Hippokratia       Date:  2007-07       Impact factor: 0.471

Review 7.  Role of varicocele repair for male infertility in the era of assisted reproductive technologies.

Authors:  Masaki Kimura; Koichi Nagao
Journal:  Reprod Med Biol       Date:  2014-05-17

8.  Management options of varicoceles.

Authors:  Peter Chan
Journal:  Indian J Urol       Date:  2011-01

Review 9.  The role of varicocele repair in the new era of assisted reproductive technology.

Authors:  Marcello Cocuzza; Mariana Amora Cocuzza; Frances Monette Papa Bragais; Ashok Agarwal
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365

10.  Comparison of recombinant human follicle stimulating hormone (rhFSH), human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG) on semen parameters after varicocelectomy: a randomized clinical trial.

Authors:  Mohammad Ali Amirzargar; Mahnaz Yavangi; Abbass Basiri; Sayyed Mahdi Hosseini Moghaddam; Hooshang Babbolhavaeji; Nasibeh Amirzargar; Hossein Amirzargar; Leila Moadabshoar
Journal:  Iran J Reprod Med       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.